Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Valneva SE

Start price
Target price
Perf. (%)
€29.96
30.11.21
€35.00
30.11.22
-66.46%
12.08.22

Could be very worthwhile Investment >20% year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.48
30.11.21
-
30.11.22
-50.67%
10.08.22

Could be worthwhile Investment >10% per year
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€9.20
15.10.21
€11.50
15.10.22
-61.67%
07.08.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.22
18.06.22
-
18.06.23
-4.50%
26.06.22

buy
Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.36
28.05.22
-
28.05.23
-5.93%
18.06.22

DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.39
09.06.22
-
09.06.23
-18.78%
11.06.22

Avadel Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€2.36
28.05.22
€1.00
28.05.23
-5.93%
11.06.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€12.30
27.04.22
-
27.05.22
-6.54%
28.05.22

buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
buy
Valneva SE

Start price
Target price
Perf. (%)
€16.80
14.04.22
€30.00
14.05.22
-46.73%
15.05.22

Virbac S.A.

Start price
Target price
Perf. (%)
€279.00
19.04.21
-
19.04.22
35.48%
20.04.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.21
05.03.22
€1.00
05.03.23
35.37%
19.03.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
09.02.22
-
09.03.22
-0.86%
10.03.22

buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€10.68
07.03.21
€11.00
07.03.22
26.50%
07.03.22

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.01
19.02.22
€4.00
19.02.23
-11.75%
05.03.22

buy
Poxel S.A.

Start price
Target price
Perf. (%)
€4.07
15.02.22
€5.00
15.03.22
-25.36%
20.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€14.84
15.02.22
-
15.02.23
0.61%
20.02.22

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.36
06.02.22
€3.70
06.02.23
-10.41%
19.02.22

buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.37
24.11.21
€6.00
24.11.22
-24.21%
15.02.22

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year